Inactive Instrument

Hospira, Inc. Share Price

Stocks

US4410601003

Pharmaceuticals

End-of-day quote NYSE Other stock markets
- ^USD	-

04/15/04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/15/28	Allergan : Mylan independence from Teva's embrace comes with a price	RE

Latest news : Hospira, Inc.

04/15/04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/15/28	Allergan : Mylan independence from Teva's embrace comes with a price	RE
14/15/14	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal	RE
03/15/03	Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount	RE
07/15/07	Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal	RE
14/15/14	AbbVie : Banks see talent flee amid healthcare M&A boom	RE
09/15/09	Actavis : Generic drugmaker Mylan offers $29 billion for Perrigo	RE
05/15/05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
05/15/05	AbbVie : Biotech buys get pharma M&A off to flying start in 2015	RE
05/15/05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
25/15/25	Celltrion : Biosimilar copies of blockbuster drug launch in major EU markets	RE
06/15/06	Pfizer : to buy Hospira for $15 billion to bolster hospital products	RE
06/15/06	Hospira : Pfizer's Hospira deal bets on price spike for specialty generics	RE

Press Releases: Hospira, Inc.

27/15/27	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
27/15/27	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
21/15/21	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
20/15/20	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
20/15/20	Hospira : TGA Approves First mAb Biosimilar	PR

More press releases

News in other languages: Hospira, Inc.

28/15/28	Activision Blizzard et United Continental intègrent le S&P-500
24/15/24	Apple : Les valeurs à suivre à Wall Street
24/15/24	USA-Les valeurs à suivre à Wall Street
03/15/03	American : Les valeurs à suivre sur les marchés américains
03/15/03	USA-Les valeurs à suivre à Wall Street

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.57%	+0.20%	+16.14%	+77.57%	4.83TCr
	OTSUKA HOLDINGS CO., LTD.	-0.50%	-1.00%	+59.44%	+106.88%	3.53TCr
	CIPLA LIMITED	-1.56%	-2.55%	-5.46%	+32.80%	1.18TCr
	ZYDUS LIFESCIENCES LIMITED	-1.11%	-3.48%	+15.79%	+81.46%	1.16TCr
	KRKA, D. D.	-0.84%	-0.19%	+36.48%	+136.73%	899.08Cr
	ONO PHARMACEUTICAL CO., LTD.	-0.27%	+2.22%	+47.65%	-7.23%	692.87Cr
	GEDEON RICHTER	-0.60%	-3.31%	+13.85%	+30.90%	672.41Cr
	GLENMARK PHARMACEUTICALS LIMITED	+0.24%	-3.58%	+3.10%	+179.73%	643.36Cr
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.47%	-10.97%	-31.86%	+6.76%	566.47Cr
	Average	-0.73%	-2.92%	+17.23%	+71.73%	1.58TCr
	Weighted average by Cap.	-0.33%	-1.35%	+25.30%	+80.65%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!

×